P001373

A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.

The Journal of clinical endocrinology and metabolism · 1996 · 10.1210/jcem.81.1.8550766

Courtesy of the U.S. National Library of Medicine. This snapshot may differ from current PubMed records. NLM does not endorse this site.

Topic
Congenital adrenal hyperplasia (CAH)

Cite this resource

DSD Research Library | A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia. | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/papers/P001373?version=v1.4.0